Susanne Antonie Schaffert
Director/Board Member presso INCYTE CORPORATION
Patrimonio netto: 14 M $ in data 31/03/2024
Profilo
Susanne Antonie Schaffert is currently an Independent Director at Incyte Corp.
and an Independent Non-Executive Director at Galapagos NV.
She also holds positions as a Director at Novo Holdings AS (Denmark), Vetter Pharma International GmbH, Artbio, Inc., CIBA Vision GmbH (Germany), and E.
Merck KG.
In her former roles, Schaffert served as the President & Chief Executive Officer at Novartis Oncology, Inc. from 2019 to 2022.
She was also the Chairman & President at Advanced Accelerator Applications SA from 2018 to 2019.
Additionally, she held the position of Director at Endocyte, Inc. and Rubius Therapeutics, Inc. from 2022 to 2023.
Prior to that, she was the Global Head-Investor Relations at Novartis AG from 2011 to 2012.
Schaffert obtained her graduate and doctorate degrees from Friedrich-Alexander University of Erlangen-Nuremberg.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NOVARTIS AG
0.01% | 31/12/2022 | 142 844 ( 0.01% ) | 14 M $ | 31/03/2024 |
INCYTE CORPORATION
0.00% | 14/06/2023 | 10 393 ( 0.00% ) | 592 089 $ | 31/03/2024 |
GALAPAGOS NV
0.00% | 15/03/2024 | 360 ( 0.00% ) | 11 501 $ | 31/03/2024 |
Posizioni attive di Susanne Antonie Schaffert
| Società | Posizione | Inizio |
|---|---|---|
| INCYTE CORPORATION | Director/Board Member | 01/10/2022 |
| GALAPAGOS NV | Director/Board Member | 12/06/2023 |
CIBA Vision GmbH (Germany)
 CIBA Vision GmbH (Germany) Electronic ComponentsElectronic Technology Part of Alcon AG, CIBA Vision GmbH is a private company based in Grosswallstadt, Germany. CIBA Vision GmbH manufactures and markets contact lenses. The German company was founded in 1983. The CEO is Norbert Dörr. | Director/Board Member | - |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Director/Board Member | - |
Artbio, Inc.
 Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021. | Director/Board Member | - |
Vetter Pharma International GmbH
 Vetter Pharma International GmbH Medical DistributorsDistribution Services Part of Vetter Pharma-Fertigung Verwaltungs GmbH, Vetter Pharma International GmbH is a pharmaceutical service provider that offers comprehensive fill-and-finish services from clinical development to commercialization and beyond. The private company is based in Ravensburg, Germany. The German company uses robust, well-controlled testing procedures to verify the quality of every product they release. Vetter is a family-owned company that provides expert manufacturing guidance for injectable drug products. The company has an exclusive collection of in-depth videos that customers can explore. Recently, they responded to increasing market demand by implementing additional equipment for aseptic production and expanding storage capacities at the clinical site. The company was founded in 2009, and the CEO is Peter Sölkner. | Director/Board Member | - |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Corporate Officer/Principal | - |
Precedenti posizioni note di Susanne Antonie Schaffert
| Società | Posizione | Fine |
|---|---|---|
| RUBIUS THERAPEUTICS | Director/Board Member | 31/01/2023 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Chief Executive Officer | 01/04/2022 |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formazione di Susanne Antonie Schaffert
| Friedrich-Alexander University of Erlangen-Nuremberg | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| GALAPAGOS NV | Health Technology |
| NOVARTIS AG | Health Technology |
| Aziende private | 9 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
Vetter Pharma International GmbH
Vetter Pharma International GmbH Medical DistributorsDistribution Services Part of Vetter Pharma-Fertigung Verwaltungs GmbH, Vetter Pharma International GmbH is a pharmaceutical service provider that offers comprehensive fill-and-finish services from clinical development to commercialization and beyond. The private company is based in Ravensburg, Germany. The German company uses robust, well-controlled testing procedures to verify the quality of every product they release. Vetter is a family-owned company that provides expert manufacturing guidance for injectable drug products. The company has an exclusive collection of in-depth videos that customers can explore. Recently, they responded to increasing market demand by implementing additional equipment for aseptic production and expanding storage capacities at the clinical site. The company was founded in 2009, and the CEO is Peter Sölkner. | Distribution Services |
CIBA Vision GmbH (Germany)
CIBA Vision GmbH (Germany) Electronic ComponentsElectronic Technology Part of Alcon AG, CIBA Vision GmbH is a private company based in Grosswallstadt, Germany. CIBA Vision GmbH manufactures and markets contact lenses. The German company was founded in 1983. The CEO is Norbert Dörr. | Electronic Technology |
Artbio, Inc.
Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021. | Health Services |
E. Merck KG
E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Health Technology |
- Borsa valori
- Insiders
- Susanne Antonie Schaffert
